In addition, Choi et al. reported an elevated LOXL2 expression level in HCC tissue compared to non-tumor tissue, suggesting that LOXL2 positivity may serve as a predictive factor for poor OS and disease-specific survival (DSS) [44]. This evidence concerns the gene LOXL2 and neoplasm.